Last updated: February 12, 2026
Sponsor: Wake Forest University Health Sciences
Overall Status: Active - Not Recruiting
Phase
1
Condition
Hair Loss
Alopecia
Treatment
usual medication for CCCA
azelaic acid
Clinical Study ID
NCT05416333
IRB00076717
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
women eighteen years of age or older
biopsy-proven and /or clinical diagnosis of CCCA Stage II-IV
on stable treatment without changes for at least three months
recruited from outpatient dermatology clinics at the Wake Forest Baptist HealthDepartment of Dermatology
Exclusion
Exclusion Criteria:
- males
Study Design
Total Participants: 18
Treatment Group(s): 2
Primary Treatment: usual medication for CCCA
Phase: 1
Study Start date:
August 12, 2024
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Wake Forest University Health Scieces
Winston-Salem, North Carolina 27157
United StatesSite Not Available
Wake Forest University Health Scieces
Winston-Salem 4499612, North Carolina 4482348 27157
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.